Clinical Trials
7
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study of HBS-201 (Pitolisant Delayed-release)
- Conditions
- Narcolepsy
- Interventions
- Drug: HBS-201
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT07051252
- Locations
- 🇺🇸
Harmony Site 9, San Ramon, California, United States
🇺🇸Harmony Site 14, Brandon, Florida, United States
🇺🇸Harmony Site 4, Miami, Florida, United States
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
- Conditions
- Drug Interaction
- Interventions
- Drug: Part 1Drug: Part 2
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06930872
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
A Study of Pitolisant in Patients With Prader-Willi Syndrome
- Conditions
- Prader-Willi Syndrome
- Interventions
- Other: Placebo tablet
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 134
- Registration Number
- NCT06366464
- Locations
- 🇺🇸
Santa Monica Clinical Trials, Los Angeles, California, United States
🇺🇸Center of Excellence in Diabetes and Endocrinology, Sacramento, California, United States
🇺🇸Rady Children's Hospital - Scan Diego, San Diego, California, United States
WAKIX® (Pitolisant) Pregnancy Registry
- Conditions
- Pregnancy RelatedNarcolepsy
- Interventions
- Drug: Comparator Products
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 1329
- Registration Number
- NCT05536011
- Locations
- 🇺🇸
Evidera (PPD), Morrisville, North Carolina, United States
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
- Conditions
- Idiopathic HypersomniaExcessive Daytime Sleepiness
- Interventions
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT05458128
- Locations
- 🇺🇸
Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, United States
🇺🇸Sleep Dynamics, Neptune City, New Jersey, United States
🇺🇸Cedars-Sinai Medical Towers, Los Angeles, California, United States
- Prev
- 1
- 2
- Next
News
Cannabinoid Drug Development Accelerates with 50+ Companies Advancing Clinical Trials
DelveInsight reports over 50 pharmaceutical companies are actively developing 55+ cannabinoid therapies across various clinical stages, representing significant momentum in the therapeutic cannabis space.